↓ Skip to main content

Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?

Overview of attention for article published in this source, April 2024
Altmetric Badge

Mentioned by

twitter
3 X users

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?
Published by
American Medical Association (AMA), April 2024
DOI 10.1001/amajethics.2024.306
Pubmed ID
Authors

Matt Christian, Wejdan Bagais

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.